Pulmonary Hypertension (PH) Terminated Phase Trials for Regadenoson (DB06213)

Also known as: Hypertension, Pulmonary / Pulmonary; Hypertension / Pulmonary hypertension / Hypertension Pulmonary / Pulmonary hypertensions / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02220634Regadenoson for Acute Vasoreactivity Testing in Pulmonary HypertensionTreatment